Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 6Burkitt Lymphoma 6Neoplasm, Residual 3Leukemia 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms by Histologic Type 1Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, B-Cell 1Lymphoma 1Lymphatic Diseases 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoproliferative Disorders 1

Interventions

venetoclax 5Dexamethasone 5Cytarabine 3Cyclophosphamide 3Vincristine 2Decitabine 2trametinib 1ruxolitinib 1pegaspargase 1nilotinib 1navitoclax 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1blinatumomab 1Vorinostat 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Dasatinib 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × blinatumomab × Clear all
NCT03114865 2025-05-22

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting
44 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡